Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jeanne, Maruani"'
Autor:
R. Alonso, Jean pierre Martinolle, Sarran Lionel, Jeanne Maruani, Annie Cudennec, Claudine Planchenault, Bernard Ferrari, Olivier Finance, Gérard Le Fur, Philippe Soubrie, Tiziano Croci, Katalin Urban-Szabo, Jean Gougat, Fabio Guagnini, Martine Poncelet
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 309:661-669
The biochemical and pharmacological properties of a novel non-peptide antagonist of the bradykinin (BK) B1 receptor, SSR240612 [(2 R )-2-[((3 R )-3-(1,3-benzodioxol-5-yl)-3-{[(6-methoxy-2-naphthyl)sulfonyl]amino}propanoyl)amino]-3-(4-{[2 R ,6 S )-2,6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30ce65525c47d5827a4439d1946d280e
https://doi.org/10.1124/jpet.103.059527
https://doi.org/10.1124/jpet.103.059527
Autor:
David Shire, J. C. Breliere, Daniel Caput, Francis Barth, Michel Heaulme, P. Ferrara, Gérard Le Fur, Murielle Rinaldi-Carmona, Christian Congy, Jeanne Maruani, Serge Martinez, Philippe Soubrie, Bernard Calandra, Gervais Neliat
Publikováno v:
FEBS Letters. 350:240-244
SR141716A is the first selective and orally active antagonist of the brain cannabinoid receptor. This compound displays nanomolar affinity for the central cannabinoid receptor but is not active on the peripheral cannabinoid receptor. In vitro, SR1417
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13c4c438b6cb58591f388a80da549c64
https://doi.org/10.1016/0014-5793(94)00773-x
https://doi.org/10.1016/0014-5793(94)00773-x
Autor:
J. Souilhac, J.C. Brelière, R. Calassi, X. Emonds-Alt, Philippe Soubrie, G. Le Fur, Jeanne Maruani, Christiane Gueudet, M. Jung, M. Poncelet, M.C. Barnouin
Publikováno v:
Neuropharmacology. 33:167-179
SR 140333 (1-2-[3-(3,4-dichlorophenyl)-1-(3-isopropoxyphenylacetyl)piperidin-3-yl]ethyl-4-phenyl -1-azonia-bicyclo[2.2.2]octane, chloride), a potent non peptide ligand of the substance P (SP) NK1 receptor subtype with high affinity for NK1 receptors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea20ebd19d0a5d2461d7350605796cf5
https://doi.org/10.1016/0028-3908(94)90004-3
https://doi.org/10.1016/0028-3908(94)90004-3
Autor:
Gérard Le Fur, Michele Arnone, Philippe Soubrie, Christian Congy, Didier Oustric, Olivier Finance, Murielle Rinaldi-Carmona, Jeanne Maruani, Francis Barth, Martine Poncelet, Serge Martinez, Alain Pério
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 310(3)
Based on binding, functional, and pharmacological data, this study introduces SR147778 [5-(4-bromophenyl)-1-(2,4-dichloro-phenyl)-4-ethyl- N -(1-piperidinyl)-1 H -pyrazole-3-carboxamide] as a highly potent, selective, and orally active antagonist for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c554dec446c988c9ff9aa59a7331aa17
https://pubmed.ncbi.nlm.nih.gov/15131245
https://pubmed.ncbi.nlm.nih.gov/15131245
Autor:
Jean, Gougat, Bernard, Ferrari, Lionel, Sarran, Claudine, Planchenault, Martine, Poncelet, Jeanne, Maruani, Richard, Alonso, Annie, Cudennec, Tiziano, Croci, Fabio, Guagnini, Katalin, Urban-Szabo, Jean-Pierre, Martinolle, Philippe, Soubrié, Olivier, Finance, Gérard, Le Fur
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 309(2)
The biochemical and pharmacological properties of a novel non-peptide antagonist of the bradykinin (BK) B(1) receptor, SSR240612 [(2R)-2-[((3R)-3-(1,3-benzodioxol-5-yl)-3-[[(6-methoxy-2-naphthyl)sulfonyl]amino]propanoyl)amino]-3-(4-[[2R,6S)-2,6-dimet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c77c3caa8f2091b5d1e9ee1342445fd8
https://pubmed.ncbi.nlm.nih.gov/14747609
https://pubmed.ncbi.nlm.nih.gov/14747609
Publikováno v:
Neuroscience letters. 343(3)
Administration of the cannabinoid CB1 receptor antagonist SR141716 (3–10 mg/kg i.p.) abolished neuropeptide Y-induced overeating and significantly reduced ethanol and sucrose intake in CB1 wild-type (+/+) mice. In CB1 receptor knockout (−/−) mi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3abd584ad30ce26bd0fee4c6bf17e2fe
https://pubmed.ncbi.nlm.nih.gov/12770700
https://pubmed.ncbi.nlm.nih.gov/12770700
Autor:
Michele Arnone, M. Poncelet, Philippe Soubrie, Jeanne Maruani, Marie-Hélène Thiébot, G Le Fur, Frederique Chaperon
Publikováno v:
Psychopharmacology. 132(1)
SR 141716, a selective central CB1 cannabinoid receptor antagonist, markedly and selectively reduces sucrose feeding and drinking as well as neuropeptide Y-induced sucrose drinking in rats. SR 141716 also decreases ethanol consumption in C57BL/6 mice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba3f8cbe41b2ad75f881900bafd661ff
https://pubmed.ncbi.nlm.nih.gov/9272766
https://pubmed.ncbi.nlm.nih.gov/9272766
Publikováno v:
Behavioural Pharmacology. 7:65
Active cannabimimetic drugs are known to bind to two receptor subtypes: one, called CB1, is mainly localised in the central nervous system while the other (CB2) is expressed preferentially in the immune system. SR 141716A has been demonstrated to hav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::700b31a6f65cea8fc6f980b59f0c1314
https://doi.org/10.1097/00008877-199601000-00006
https://doi.org/10.1097/00008877-199601000-00006
Autor:
Murielle, Rinaldi-Carmona, Francis, Barth, Christian, Congy, Serge, Martinez, Didier, Oustric, Alain, Prio, Martine, Poncelet, Jeanne, Maruani, Michle, Arnone, Olivier, Finance, Philippe, Soubri, Grard, Le Fur
Publikováno v:
The Journal of Pharmacology and Experimental Therapeutics; September 2004, Vol. 310 Issue: 3 p905-14, 10p